Correction: Encapsulation of the dual FLAP/mPEGS‑1 inhibitor BRP‑187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity
- PMID: 38408973
- PMCID: PMC10898008
- DOI: 10.1186/s12951-024-02341-7
Correction: Encapsulation of the dual FLAP/mPEGS‑1 inhibitor BRP‑187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity
Erratum for
-
Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity.J Nanobiotechnology. 2020 May 14;18(1):73. doi: 10.1186/s12951-020-00620-7. J Nanobiotechnology. 2020. PMID: 32408877 Free PMC article.
References
-
- Shkodra B, Kretzer C, Jordan PM, Klemm P, Koeberle A, Pretzel D, Banoglu E, Lorkowski S, Wallert M, Höppener S, Stumpf S, Vollrath A, Schubert S, Werz O, Schubert US. Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity. J Nanobiotechnol. 2020;18:73. doi: 10.1186/s12951-020-00620-7. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
